ACM
RMD icon

Altium Capital Management’s ResMed RMD Stock Holding History

Altium Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26,000
Closed -$5.95M – 57
2024
Q4 		$5.95M Buy
+26,000
New +$6.26M 1.69% 21
2023
Q2 		– Sell
-17,000
Closed -$3.72M – 91
2023
Q1 		$3.72M Hold
17,000
– – 2.07% 17
2022
Q4 		$3.54M Hold
17,000
– – 1.8% 21
2022
Q3 		$3.71M Buy
+17,000
New +$3.87M 1.36% 26

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Altium Capital Management's RMD Position: Q1 2025 in Review

Altium Capital Management sold out of ResMed (RMD) in Q1 2025, closing a stake of 26,000 shares — an estimated $5.95M sold.

Altium Capital Management first reported a position in RMD in Q3 2022 and held it in 4 quarters. The position peaked at $5.95M in Q4 2024. 886 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Altium Capital Management reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Altium Capital Management sold 26,000 ResMed shares in Q1 2025, an estimated $5.95M.
  • Altium Capital Management first reported a position in ResMed in Q3 2022 and held it in 4 quarters.
  • Altium Capital Management's ResMed position peaked at $5.95M in Q4 2024.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Altium Capital Management's 13F filing for Q1 2025, filed 9 May 2025.